Why Pfizer’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon


  • World
  • Tuesday, 10 Nov 2020

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/File Photo

NEW YORK (Reuters) - Work to distribute the experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE is gearing up after the companies announced successful interim data earlier on Monday, but it will not be coming to local pharmacies for the general public any time soon.

The data, which sent U.S. stocks to record highs [.N], showed that the two companies' experimental vaccine is 90% effective at preventing COVID-19. They are still awaiting data on safety, which could come later this month.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

US believes Russia's attack in Ukraine showcased new missile
Haiti blasts Macron's criticism of transition council as 'unfriendly and inappropriate'
Cote d'Ivoire, EU sign new fishing agreement
North Korea's Kim accuses US of stoking tension, warns of nuclear war
Canada to give holiday tax break for groceries
U.S. stocks close higher
Slovak PM shooting suspect faces prolonged custody
Gas Leak prompts evacuation of 150 people in Prague
Nations strive for climate funding consensus as COP29 deadline nears
Biden's shift on missiles for Ukraine informed by North Korean troops in Kursk, Trump's election victory

Others Also Read